Filing Details

Accession Number:
0001209191-14-053529
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-19 18:43:54
Reporting Period:
2014-08-18
Filing Date:
2014-08-19
Accepted Time:
2014-08-19 18:43:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1125345 Macrogenics Inc MGNX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587487 Marc Jon Wigginton C/O Macrogenics, Inc.
9640 Medical Center Drive
Rockville MD 20850
Senior Vp, Clinical Dev. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-18 5,000 $4.70 5,000 No 4 M Direct
Common Stock Disposition 2014-08-18 5,000 $20.52 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-08-18 5,000 $0.00 5,000 $4.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
80,194 2023-07-18 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2014.
  2. 12.5% of the shares underlying the option became exercisable on January 19, 2014, and 6.25% of the shares underlying the option become exercisable on the first day of each three month anniversary thereafter.